XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Organization, Basis of Presentation, and Summary of Significant Accounting Policies (Tables)
3 Months Ended
Aug. 28, 2022
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents The following table provides a reconciliation of cash and cash equivalents and cash and cash equivalents, discontinued operations within the Consolidated Balance Sheets that sum to the total of the same such amounts shown in the Consolidated Statements of Cash Flows:
(In thousands)August 28, 2022May 29, 2022August 29, 2021May 30, 2021
Cash and cash equivalents$4,222 $1,643 $1,406 $1,159 
Cash and cash equivalents, discontinued operations— — 41 136 
Cash and cash equivalents$4,222 $1,643 $1,447 $1,295 
Schedule of Inventories
Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value and consist of the following:

(In thousands)August 28, 2022May 29, 2022
Finished goods$25,266 $33,029 
Raw materials27,402 24,221 
Work in progress11,617 9,595 
Total$64,285 $66,845 
Schedule of Financing Receivable, Allowance for Credit Loss
The changes in the Company’s allowance for sales returns and credit losses are summarized in the following table (in thousands):
 Balance at
beginning of
period
Provision (benefit) for expected credit lossesWrite offs,
net of
recoveries
Balance at
end of period
Three months ended August 29, 2021$85 $— $— $85 
Three months ended August 28, 2022$65 $— $— $65 
Schedule of Accumulated Other Comprehensive Loss The Company’s OCI consists of net deferred gains and losses on its interest rate swap derivative instruments. The components of AOCL, net of tax, are as follows:
(In thousands)AOCL
Balance as of May 29, 2022
$(586)
Amounts reclassified from OCI300 
Other comprehensive income, net$300 
Balance as of August 28, 2022
$(286)
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table summarizes the fair value of the Company’s assets and liabilities that are measured at fair value on a recurring and nonrecurring basis (in thousands):

Fair Value at August 28, 2022Fair Value at May 29, 2022
Assets:Level 1Level 2Level 3Level 1Level 2Level 3
Assets held for sale - nonrecurring$— $— $— $— $— $1,027 
Current assets, discontinued operations
Assets held for sale - nonrecurring— 86 — — — — 
Property & equipment, as restated$— $— $— $— $3,500 $1,400 
Customer relationships, as restated$— $— $— $— $— $4,000 
Total assets$— $86 $— $— $3,500 $6,427 
Schedule of Disaggregation of Revenue
The Company disaggregates its revenue by segment based on how it markets its products and services and reviews results of operations. The following tables disaggregate segment revenue by major product lines and services:

(In thousands)Three Months Ended
Lifecore:August 28, 2022August 29, 2021
Contract development and manufacturing organization$18,247 $17,789 
Fermentation5,456 4,163 
Total$23,703 $21,952 
(In thousands)Three Months Ended
Curation Foods:August 28, 2022August 29, 2021
Avocado products$17,093 $16,962 
Olive oil and wine vinegars2,559 2,340 
Technology— 378 
Total$19,652 $19,680 
Schedule of Error Corrections and Prior Period Adjustments
As reportedAs restated
(in thousands)August 28, 2022AdjustmentAugust 28, 2022
ASSETS
Property and equipment, net
$129,024 $(11,473)$117,551 
Trademarks/tradenames, net$8,400 $300 $8,700 
Customer relationships, net$6,875 $(5,529)$1,346 
Total Assets$285,800 $(16,702)$269,098 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Deferred tax liability, net$291 $(167)$124 
Total Liabilities$188,901 $(167)$188,734 
Accumulated deficit$(70,915)$(16,535)$(87,450)
Total Stockholders’ Equity$96,899 $(16,535)$80,364 
Total Liabilities and Stockholders’ Equity$285,800 $(16,702)$269,098 

The effects of this error on our previously reported interim consolidated statement of comprehensive (loss) income for the three-month period ended August 28, 2022 as presented in the Original Prior Quarterly Report are as follows:
Three Months Ended
As reportedAs restated
August 28, 2022AdjustmentAugust 28, 2022
Product sales$43,355 $— $43,355 
Cost of product sales37,534 (431)37,103 
Gross profit5,821 431 6,252 
Operating costs and expenses:
Research and development2,048 — 2,048 
Selling, general and administrative10,883 (222)10,661 
Restructuring costs1,047 — 1,047 
Total operating costs and expenses13,978 (222)13,756 
Operating loss(8,157)653 (7,504)
Interest income15 — 15 
Interest expense(3,678)— (3,678)
Other income (expense), net(180)— (180)
Net loss before tax(12,000)653 (11,347)
Income tax (expense) benefit(64)60 (4)
Net loss from continuing operations(12,064)713 (11,351)
Loss from discontinued operations, net of tax— — — 
Net loss$(12,064)$713 $(11,351)
Basic net loss per share:
Loss from continuing operations$(0.41)$0.03 $(0.38)
Loss from discontinued operations— — — 
Total basic net loss per share$(0.41)$0.03 $(0.38)
Diluted net loss per share:
Loss from continuing operations$(0.41)$0.03 $(0.38)
Loss from discontinued operations— — — 
Total diluted net loss per share$(0.41)$0.03 $(0.38)
Total comprehensive loss$(11,764)$713 $(11,051)
The effects of this error on our previously reported consolidated statement of changes in stockholders' equity for the year ended August 28, 2022 as presented in the Prior Quarterly Report are as follows:

As reportedAs reportedAdjustmentAs restatedAs restated
Retained
Earnings (Accumulated Deficit)
Total
Stockholders’
Equity
Retained
Earnings (Accumulated Deficit)
Total
Stockholders’
Equity
(In thousands)
Balance at May 29, 2022$(58,851)$107,945 $(17,248)$(76,099)$90,697 
Issuance of stock under stock plans, net of shares withheld— — — — — 
Taxes paid by Company for employee stock plans— (67)— — (67)
Stock-based compensation— 785 — — 785 
Net loss(12,064)(12,064)713 (11,351)(11,351)
Other comprehensive income, net of tax— 300 — — 300 
Balance at August 28, 2022$(70,915)$96,899 $(16,535)$(87,450)$80,364 

The effects of this error on our previously reported consolidated statement of cash flows for the three-month period ended August 28, 2022 as presented in the Original Prior Quarterly Report are as follows:

Three Months Ended
As reportedAs restated
(in thousands)August 28, 2022AdjustmentAugust 28, 2022
Cash flows from operating activities:
Net loss$(12,064)$713 $(11,351)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, amortization of intangibles, debt costs and right-of-use assets$5,009 $(653)$4,356 
Deferred taxes$43 $(60)$(17)
Net cash (used in) provided by operating activities$(1,533)$— $(1,533)
The effects of this error on our previously reported diluted earnings per share for the three-month period ended August 28, 2022 as presented in Note 4 - Diluted Earnings of the unaudited consolidated financial statements reported in the Original Prior Quarterly Report are as follows:

Three Months Ended
As reportedAs restated
(in thousands, except per share amounts)August 28, 2022AdjustmentAugust 28, 2022
Numerator:
Net loss$(12,064)$713 $(11,351)
Denominator:
Weighted average shares for basic and diluted net loss per share29,577 — 29,577 
Basic Diluted net loss per share$(0.41)$0.03 $(0.38)

The effects of this error on our previously reported income taxes per share for the three-month period ended August 28, 2022 as presented in Note 5 - Income Taxes of the unaudited consolidated financial statements reported in the Original Prior Quarterly Report are as follows:

Three Months Ended
As reportedAs restated
(in thousands, except effective tax rate)August 28, 2022AdjustmentAugust 28, 2022
Income tax (expense) benefit$0.1  million$(0.1) million$4.0 thousand
Effective Tax Rate0.5 %(0.5)%— %

The effects of this error on our previously reported operations by business segment for the three-month period ended August 28, 2022 as presented in Note 7 - Business Segment Reporting of the unaudited consolidated financial statements reported in the Original Prior Quarterly Report are as follows:
(In Thousands)LifecoreCuration FoodsOtherTotal
Three Months Ended August 28, 2022
Depreciation and amortization, as reported$1,771 $2,820 $11 $4,602 
Adjustment— (653)— (653)
Depreciation and amortization, as restated$1,771 $2,167 $11 $3,949 
Net income (loss) from continuing operations, as reported$502 $(3,374)$(9,192)$(12,064)
Adjustment— 653 60 713 
Net income (loss) from continuing operations, as restated$502 $(2,721)$(9,132)$(11,351)
Gross Profit, as reported$6,101 $(280)$— $5,821 
Adjustment— 431 — 431 
Gross Profit, as restated$6,101 $151 $— $6,252 
Income tax (benefit) expense, as reported$158 $(1,065)$971 $64 
Adjustment— — (60)(60)
Income tax (benefit) expense, as restated$158 $(1,065)$911 $